CFG
ABBV icon

Cooper Financial Group’s AbbVie ABBV Stock Holding History

Cooper Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.88M Buy
11,460
+2,042
+22% +$439K 0.24% 77
2026
Q1 		$2.05M Buy
9,418
+229
+2% +$50.8K 0.21% 94
2025
Q4 		$2.1M Buy
9,189
+470
+5% +$107K 0.22% 78
2025
Q3 		$2.02M Buy
8,719
+230
+3% +$46.8K 0.22% 75
2025
Q2 		$1.58M Sell
8,489
-1,569
-16% -$292K 0.19% 95
2025
Q1 		$2.11M Sell
10,058
-183
-2% -$35.6K 0.28% 69
2024
Q4 		$1.82M Buy
10,241
+668
+7% +$123K 0.22% 86
2024
Q3 		$1.89M Sell
9,573
-2,792
-23% -$521K 0.25% 72
2024
Q2 		$2.12M Sell
12,365
-663
-5% -$110K 0.31% 62
2024
Q1 		$2.37M Buy
13,028
+1,587
+14% +$274K 0.39% 44
2023
Q4 		$1.77M Buy
11,441
+659
+6% +$96.1K 0.32% 58
2023
Q3 		$1.61M Sell
10,782
-326
-3% -$47.9K 0.39% 57
2023
Q2 		$1.5M Buy
11,108
+712
+7% +$104K 0.37% 62
2023
Q1 		$1.66M Buy
10,396
+722
+7% +$110K 0.45% 50
2022
Q4 		$1.56M Buy
9,674
+2,432
+34% +$373K 0.48% 46
2022
Q3 		$972K Buy
7,242
+691
+11% +$99.2K 0.35% 72
2022
Q2 		$1M Buy
6,551
+1,137
+21% +$174K 0.36% 70
2022
Q1 		$878K Sell
5,414
-297
-5% -$43.1K 0.33% 65
2021
Q4 		$773K Sell
5,711
-3,782
-40% -$447K 0.29% 87
2021
Q3 		$1.02M Buy
9,493
+1,122
+13% +$128K 0.21% 71
2021
Q2 		$943K Buy
8,371
+1,698
+25% +$191K 0.19% 79
2021
Q1 		$722K Sell
6,673
-4,558
-41% -$488K 0.16% 91
2020
Q4 		$1.2M Buy
11,231
+4,848
+76% +$466K 0.25% 70
2020
Q3 		$559K Buy
6,383
+839
+15% +$79K 0.16% 92
2020
Q2 		$544K Buy
5,544
+352
+7% +$31K 0.18% 81
2020
Q1 		$396K Buy
5,192
+1,126
+28% +$95.9K 0.17% 90
2019
Q4 		$360K Buy
4,066
+626
+18% +$52K 0.14% 91
2019
Q3 		$261K Buy
+3,440
New +$236K 0.12% 114

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cooper Financial Group's ABBV Position: Q2 2026 in Review

Cooper Financial Group increased its AbbVie (ABBV) stake by 22% in Q2 2026, buying an estimated $439K and bringing the position to 11,460 shares worth $2.88M. The position accounts for 0.24% of the portfolio, ranked #77.

Cooper Financial Group first reported a position in ABBV in Q3 2019 and has held it in 28 quarters since. 4,207 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Cooper Financial Group held 11,460 shares of AbbVie worth $2.88M as of Q2 2026.
  • Cooper Financial Group bought 2,042 AbbVie shares in Q2 2026, an estimated $439K.
  • AbbVie made up 0.24% of Cooper Financial Group's portfolio in Q2 2026, its #77 holding.
  • Cooper Financial Group first reported a position in AbbVie in Q3 2019 and has held it in 28 quarters since.
  • 4,207 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cooper Financial Group's 13F filing for Q2 2026, filed 8 Jul 2026.